Suppressive effect of reactive oxygen species on CD40-induced B cell activation

FEBS Letters

Volumn 581, Issue 26, 2007, Pages 5043-5049

  Liu, Jiqin ^a   Yoshida, Yasuhiro ^a   Yamashita, Uki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

B cell; CD40 Signaling; ROS; TRAF2

Indexed keywords

CD40 ANTIGEN; DNA; HYDROGEN PEROXIDE; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ADAPTIVE IMMUNITY; ADOLESCENT; ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; FEMALE; IMMUNOGLOBULIN PRODUCTION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN SYNTHESIS;

ANIMALS; ANTIBODIES; ANTIGENS, CD40; B-LYMPHOCYTES; DNA; FEMALE; HYDROGEN PEROXIDE; I-KAPPA B KINASE; I-KAPPA B PROTEINS; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NF-KAPPA B; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES;

EID: 35348915487     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.09.042     Document Type: Article

References (42)

1. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
2. Iles K.E., and Forman H.J. Macrophage signaling and respiratory burst. Immunol. Res. 26 (2002) 95-105
3. Maly F.E. The B lymphocyte: a newly recognized source of reactive oxygen species with immunoregulatory potential. Free Radic. Res. Commun. 8 (1990) 143-148
4. Lee J.R., and Koretzky G.A. Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes. Eur. J. Immunol. 28 (1998) 4188-4197
5. Lee J.R. Reactive oxygen species play roles on B cell surface receptor CD40-mediated proximal and distal signaling events: effects of an antioxidant, N-acetyl-l-cysteine treatment. Mol. Cell Biochem. 252 (2003) 1-7
6. Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., and Spriggs M.K. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178 (1993) 669-674
7. Hollenbaugh D., Mischel-Petty N., Edwards C.P., Simon J.C., Denfeld R.W., Kiener P.A., and Aruffo A. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182 (1995) 33-40
8. van Kooten C., and Banchereau J. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9 (1997) 330-337
9. Foy T.M., Aruffo A., Bajorath J., Buhlmann J.E., and Noelle R.J. Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol. 14 (1996) 591-617
10. Clark L.B., Foy T.M., and Noelle R.J. CD40 and its ligand. Adv. Immunol. 63 (1996) 43-78
11. Grammer A.C., and Lipsky P.E. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv. Immunol. 76 (2000) 61-178
12. Leo E., Welsh K., Matsuzawa S., Zapata J.M., Kitada S., Mitchell R.S., Ely K.R., and Reed J.C. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation. J. Biol. Chem. 274 (1999) 22414-22422
13. Pullen S.S., Dang T.T., Crute J.J., and Kehry M.R. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J. Biol. Chem. 274 (1999) 14246-14254
14. Pullen S.S., Miller H.G., Everdeen D.S., Dang T.T., Crute J.J., and Kehry M.R. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37 (1998) 11836-11845
15. Grech A.P., Amesbury M., Chan T., Gardam S., Basten A., and Brink R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity 21 (2004) 629-642
16. Munroe M.E., and Bishop G.A. Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation. J. Biol. Chem. 279 (2004) 53222-53231 (Epub 2004 Oct 12)
17. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
18. 2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
19. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., and Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272 (1997) 217-221
20. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. 11 (1997) 118-124
21. Rhee S.G. Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31 (1999) 53-59
22. Forman H.J., Fukuto J.M., and Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am. J. Physiol. Cell Physiol. 287 (2004) C246-C256
23. Lo Y.Y., Wong J.M., and Cruz T.F. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J. Biol. Chem. 271 (1996) 15703-15707
24. Hayakawa M., Miyashita H., Sakamoto I., Kitagawa M., Tanaka H., Yasuda H., Karin M., and Kikugawa K. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J. 22 (2003) 3356-3366
25. Yoshida Y., Wang M.Q., Liu J.N., Shan B.E., and Yamashita U. Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int. J. Immunopharmacol. 19 (1997) 359-370
26. Yoshida Y., Kumar A., Koyama Y., Peng H., Arman A., Boch J.A., and Auron P.E. Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism. J. Biol. Chem. 279 (2004) 1768-1776 (Epub 2003 Oct 30)
27. Gugasyan R., Grumont R., Grossmann M., Nakamura Y., Pohl T., Nesic D., and Gerondakis S. Rel/NF-kappaB transcription factors: key mediators of B-cell activation. Immunol. Rev. 176 (2000) 134-140
28. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
29. Yaron A., et al. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature 396 (1998) 590-594
30. Klebanoff S.J. Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 93 (1980) 480-489
31. Bellosillo B., Villamor N., Lopez-Guillermo A., Marce S., Esteve J., Campo E., Colomer D., and Montserrat E. Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species. Blood 98 (2001) 2771-2777
32. Villamor N., Montserrat E., and Colomer D. Cytotoxic effects of B lymphocytes mediated by reactive oxygen species. Curr. Pharm. Des. 10 (2004) 841-853
33. Ha Y.J., and Lee J.R. Role of TNF receptor-associated factor 3 in the CD40 signaling by production of reactive oxygen species through association with p40phox, a cytosolic subunit of nicotinamide adenine dinucleotide phosphate oxidase. J. Immunol. 172 (2004) 231-239
34. Zhu Q.S., Xia L., Mills G.B., Lowell C.A., Touw I.P., and Corey S.J. G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth. Blood 107 (2006) 1847-1856 (Epub 2005 Nov 10)
35. Hostager B.S., Haxhinasto S.A., Rowland S.L., and Bishop G.A. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J. Biol. Chem. 278 (2003) 45382-45390 (Epub 2003 Sep 4)
36. Grossmann M., O'Reilly L.A., Gugasyan R., Strasser A., Adams J.M., and Gerondakis S. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19 (2000) 6351-6360
37. Liou H.C., and Hsia C.Y. Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease. Bioassays 25 (2003) 767-780
38. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 (2002) S81-S96
39. Brown K.D., Hostager B.S., and Bishop G.A. Regulation of TRAF2 signaling by self-induced degradation. J. Biol. Chem. 277 (2002) 19433-19438
40. Moore C.R., and Bishop G.A. Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes. J. Immunol. 175 (2005) 3780-3789
41. Lu L.F., Ahonen C.L., Lind E.F., Raman V.S., Cook W.J., Lin L.L., and Noelle R.J. The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation. Blood 110 (2007) 193-200
42. Jabara H., Laouini D., Tsitsikov E., Mizoguchi E., Bhan A., Castigli E., Dedeoglu F., Pivniouk V., and Brodeur S. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 17 (2002) 265-276